1. HBW Insight

CBD Public Hearing Could Extend FDA's Hand Further For Help From Congress

 
• By Malcolm Spicer

Among comments submitted to FDA's docket in advance of public hearing May 31, National Organization for the Reform of Marijuana Laws' suggestions perhaps point to path ahead for agency. "Regulations governing the production, sale, quality, and marketing of these products must take place far more expeditiously in order to protect consumer safety," the group says. FDA already appealed to Congress in its notice about docket and hearing, says attorney Coleen Klasmeier. "The notice is really a comment directed to Congress."

CBD Molecule

The US Food and Drug Administration's series of broad questions to guide its consideration on using hemp and cannabidiol as dietary ingredients has attracted many responses commenting on topics outside the agency's questions.

Among the 776 comments submitted to the "Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds" docket in advance of a public hearing the FDA is conducting May 31, the National Organization for the Reform of Marijuana Laws'

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation